---
category: news
title: "BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights"
excerpt: "Received FDA approval of IGALMI™ (dexmedetomidine) sublingual film for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults Top-line data readout in Q4 2022/early Q1 2023 for TRANQUILITY II Phase 3 trial evaluating BXCL501 in acute treatment of agitation associated with Alzheimer’s disease Extended cash runway into 2025 with $260 million strategic financing for IGALMI commercial launch and clinical and regulatory milestones U."
publishedDateTime: 2022-05-09T11:03:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/covid-technology-health-business-mental-3717bf59c739265c231f90dcf287f725"
webUrl: "https://apnews.com/press-release/globe-newswire/covid-technology-health-business-mental-3717bf59c739265c231f90dcf287f725"
type: article
quality: 10
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "BigBear.ai Announces First Quarter 2022 Financial Results"
    excerpt: "BigBear.ai Holdings, Inc. (NYSE: BBAI) (“BigBear.ai” or the “Company”), a leader in AI-powered analytics and cyber engineering solutions, today announced financial results for the first quarter of 2022."
    publishedDateTime: 2022-05-09T20:15:00Z
    webUrl: "https://finance.dailyherald.com/dailyherald/article/bizwire-2022-5-9-bigbearai-announces-first-quarter-2022-financial-results"
    type: article
    provider:
      name: Daily Herald
      domain: dailyherald.com
    quality: 17
  - title: "BigBear.ai (NYSE:BBAI) Downgraded to Sell at Zacks Investment Research"
    excerpt: "BigBear.ai (NYSE:BBAI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “BigBear."
    publishedDateTime: 2022-05-09T21:36:00Z
    webUrl: "https://www.defenseworld.net/2022/05/09/bigbear-ai-nysebbai-downgraded-to-sell-at-zacks-investment-research-2.html"
    type: article
    provider:
      name: Defense World
      domain: defenseworld.net
    quality: 17

secured: "lmVejGotolj4JXGhv7KSls37Ix7bCahSeMRCwiccBxHgL31rsy5PSvBVZFrPwNwoXpmt9ueeHYfNsDZj1ZUocaaBqhsjSdiUJhxrhqP3gGGubZWug0rDUm6yBh/dTACPxP9S1WsptwO0yQUspmB+NlxXTVNHlLwdI0G36oDGavlHXPFFRgSt3oy5MbEQz71JSmj0GFibAK3A7780NM7I3luwH0vtLBSWfyZaYxTfDkjNmTCgJDhEiyfx636Jbqem1+tso2oGXsh81sb56FvFQVPp0hMPrPMba+LKzOlla8I4UUmI97G3JB+gJuKwdPxsAlMgZIUtBMhAypjnrcsKxuFkzCflDPWnOxdsy+7H/2E=;1pGC73VlyaGx1HmCwwb70Q=="
---

